PACB
Pacific Biosciences of California Inc. Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$1.160
Máximo
$1.160
Mínimo
$1.160
Volume
8.25M
Fundamentos da empresa
Estatísticas de negociação
Notícias relacionadas
Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date
Target ALS, a nonprofit breaking down barriers to amyotrophic lateral sclerosis (ALS) research, has partnered with PacBio (Nasdaq: PACB), a leading...
PacBio to Present at Upcoming Investor Conferences
MENLO PARK, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the
PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene
MENLO PARK, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading provider of high-quality, highly accurate sequencing solutions, today announced the appointment of Haorui Gene, a globally recognized
Piper Sandler Maintains Neutral on Pacific Biosciences, Lowers Price Target to $1.25
Piper Sandler analyst David Westenberg maintains Pacific Biosciences with a Neutral and lowers the price target from $2 to $1.25.
Stephens & Co. Reiterates Overweight on Pacific Biosciences, Maintains $1.8 Price Target
Stephens & Co. analyst Mason Carrico reiterates Pacific Biosciences with a Overweight and maintains $1.8 price target.
Ações relacionadas
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.